Product Code: GVR-4-68040-540-9
Veterinary DNA Testing Market Growth & Trends:
The global veterinary DNA testing market size is expected to reach USD 838.01 Million by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a lucrative CAGR of 10.36% from 2025 to 2030. Consumer genomics has significantly advanced in the recent decade, with companies advertising human DNA testing services on the subways and radios. This genomic revolution has now reached the veterinary industry, with key players offering various iterations of dog and cat DNA test kits to breeders, pet parents, and veterinarians. The convenience of these at-home test kits enables people to share just the buccal swab samples of their pets to determine genetic disease susceptibility, breed mixes, possible physical traits such as fur color, eye color, age, ancestral information, drug sensitivities, and so on.
Owing to the growing applications of genetic tests for allergies and cancers in humans, such products are also getting into pet markets with vast growth opportunities. With major players in the market, such as Embark Veterinary, Inc., Mars (Wisdom Panel), DNA My Dog, OptiGen, and Paw Print Genetics, pet parents have many options to choose from at affordable prices. In addition, animal owners, especially millennials, are willing to spend money on their pets' healthcare. DNA testing has shown several potential benefits for companion animals by providing information that the owner needs to prepare their pets for the future. Knowing certain genetic hereditary diseases in advance enables owners to start timely treatments, also potentially avoiding costly medication or diagnostic bills later on. Current generations are widely active on social media, allowing them to adapt to new pet trends quickly. This factor is increasing awareness among pet parents regarding pet breed test products, their ease of use, and their enormous applications.
Pet parents are known for spending money to keep their pets happy & healthy with various advanced products. Their keen interest in understanding pets' age, breed mix, and ancestral relations allows owners to guess their pet's behavior patterns and provide the required training. Furthermore, the increased interest of people in the U.S. in specific pet breed categories has increased the requirement for breed testing and its products among professional breeders. Using veterinary DNA testing and genetic profiling before breeding procedures prevents breeders from producing at-risk disease puppies. Therefore, owing to these affirmative factors, awareness and sales of veterinary DNA testing products are expected to grow in the long run.
Research activities for DNA testing-based products have significantly evolved in veterinary medicine in the last decade, which has provided notable clinical evidence supporting the application of these tests. Amid detailed research on human genetic codes, studies are being conducted to analyze animal DNA. Moreover, dogs were chosen as research targets for DNA-based studies because breeding practices over the past two decades have made scientists understand the loss of genetic diversity, also called genetic drifts, within a few breeds.
In the early 2000s, dog genome projects were initiated to understand ways of learning disease susceptibility among companion animals. With several years of research & technological improvement, DNA technology has lowered costs with easy breed detection kits at doorsteps. Key players offer multidrug resistance 1 (MDR1) veterinary DNA tests to screen conditions such as degenerative myelopathy, exercise-induced collapse testing, hyperuricosuria DNA test for uric acid, von Willebrand disease DNA testing, and PRCD-pra testing. Therefore, research interest in veterinary DNA testing technology will drive market growth.
Veterinary DNA Testing Market Report Highlights:
- The industry is experiencing and is expected to experience an increasing degree of innovation. This is mainly owing to extensive research projects being conducted worldwide. These projects include pets like dogs and cats and other species like cattle, horses, sheep, and turtles. The initiatives are increasing the innovative variety of products available in the industry.
- The fecal segment is expected to grow the fastest by sample type during the forecast period. Compared to other samples like blood, semen, hair, tissue, teeth, bone, vomit, organ, urine, etc., fecal sample collection is the second best after saliva. It is non-invasive, barring the issue of animal compliance, and the collector can easily take this sample after an animal defecates.
- Based on test, the breed profile segment held the largest share of 41.4% in 2024. This can be due to their accuracy in identifying an animal's genetic makeup, which assists in determining its ancestry and potential health risks associated with specific breeds.
- The UK market is the most lucrative in Europe, with the largest share in 2024, and is projected to register the highest growth rate over 2025 - 2030. In recent years, the UK has been very active in various initiatives like novel product launches, cross-species research projects, exploring applications of DNA tests in different animals, attracting international players to the domestic market, and many more.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Regional Scope
- 1.1.2. Estimates And Forecast Timeline
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis
- 1.6.2. Global Market: CAGR Calculation
- 1.7. Research Scope and Assumptions
- 1.7.1. List of Secondary Sources
- 1.7.2. List of Primary Sources
- 1.7.3. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Veterinary DNA Testing Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
- 3.2.1.1. Increasing Popularity of DNA Testing
- 3.2.1.2. Efforts to Spread Awareness and Education
- 3.2.1.3. Emergence of Novel Research Projects
- 3.2.1.4. Increasing Exploratory Studies in Multiple Species
- 3.2.2. Market Restraints Analysis
- 3.2.2.1. Potential for Inaccurate Results
- 3.2.2.2. Lack of Standard Regulations
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenges Analysis
- 3.3. Veterinary DNA Testing Market Analysis Tools
- 3.3.1. Porter's Analysis
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental Landscape
- 3.3.2.5. Legal landscape
- 3.4. Covid-19 Analysis
- 3.5. Estimated Pet Population, 2018 - 2023, by Key Species & Key Countries
- 3.6. Regulatory & Reimbursement Landscape
- 3.7. Pricing Analysis
- 3.8. Key Research Case Studies
- 3.9. User Perspective Analysis
- 3.9.1. Pet Owner Demographic Profile & Perspective Analysis
- 3.9.2. Breeders' Perspective Analysis
- 3.9.3. Veterinarians' Perspective Analysis
- 3.10. COVID-19 Impact Analysis
Chapter 4. Veterinary DNA Testing Market: Animal Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Veterinary DNA Testing Market Movement Analysis
- 4.3. Global Veterinary DNA Testing Market Size & Trend Analysis, by Animal, 2018 to 2030 (USD Million)
- 4.4. Dogs
- 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5. Cats
- 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.6. Other Animals
- 4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Veterinary DNA Testing Market: Sample Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Veterinary DNA Testing Market Movement Analysis
- 5.3. Global Veterinary DNA Testing Market Size & Trend Analysis, by Sample, 2018 to 2030 (USD Million)
- 5.4. Blood
- 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.5. Saliva
- 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.6. Fecal
- 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.7. Others
- 5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Veterinary DNA Testing Market: Test Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Veterinary DNA Testing Market Movement Analysis
- 6.3. Global Veterinary DNA Testing Market Size & Trend Analysis, by Test, 2018 to 2030 (USD Million)
- 6.4. Breed Profile
- 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.5. Genetic Diseases
- 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.6. Health and Wellness
- 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Veterinary DNA Testing Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Global Veterinary DNA Testing Market Movement Analysis
- 7.3. Global Veterinary DNA Testing Market Size & Trend Analysis, End Use, 2018 to 2030 (USD Million)
- 7.4. Veterinarians & Researchers
- 7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5. Animal Breeders
- 7.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6. Animal Owners
- 7.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Veterinary DNA Testing Market: Regional Estimates & Trend Analysis
- 8.1. Regional Dashboard
- 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030 North America
- 8.3. North America
- 8.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. U.S. Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Canada Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.4. Mexico
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Mexico Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4. Europe
- 8.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.4.2. U.K.
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. U.K. Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Germany
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Germany Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. France
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. France Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Italy Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Spain Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Sweden
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Sweden Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.8. Denmark
- 8.4.8.1. Key Country Dynamics
- 8.4.8.2. Denmark Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.9. Norway
- 8.4.9.1. Key Country Dynamics
- 8.4.9.2. Norway Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.2. China
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. China Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Japan
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Japan Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. India
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. India Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. South Korea
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. South Korea Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Australia
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Australia Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. Thailand
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Thailand Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Brazil
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Brazil Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Argentina
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Argentina Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7. Middle East and Africa
- 8.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.7.2. Saudi Arabia
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Saudi Arabia Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. South Africa
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. South Africa Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.4. UAE
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. UAE Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.5. Kuwait
- 8.7.5.1. Key Country Dynamics
- 8.7.5.2. Kuwait Veterinary DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Company Market Position Analysis/ Heat Map Analysis
- 9.3. Estimated Company Market Share Analysis, 2024
- 9.4. Strategy Mapping
- 9.4.1. Mergers & Acquisitions
- 9.4.2. Partnerships & Collaborations
- 9.4.3. Others
- 9.5. Company Profiles
- 9.5.1. EasyDNA
- 9.5.1.1. Participant's Overview
- 9.5.1.2. Financial Performance
- 9.5.1.3. Product Benchmarking
- 9.5.1.4. Strategic Initiatives
- 9.5.2. Wisdom Panel (Mars Inc.)
- 9.5.2.1. Participant's Overview
- 9.5.2.2. Financial Performance
- 9.5.2.3. Product Benchmarking
- 9.5.2.4. Strategic Initiatives
- 9.5.3. Macrogen, Inc.
- 9.5.3.1. Participant's Overview
- 9.5.3.2. Financial Performance
- 9.5.3.3. Product Benchmarking
- 9.5.3.4. Strategic Initiatives
- 9.5.4. Embark Veterinary, Inc.
- 9.5.4.1. Participant's Overview
- 9.5.4.2. Financial Performance
- 9.5.4.3. Product Benchmarking
- 9.5.4.4. Strategic Initiatives
- 9.5.5. The Royal Kennel Club Ltd.
- 9.5.5.1. Participant's Overview
- 9.5.5.2. Financial Performance
- 9.5.5.3. Product Benchmarking
- 9.5.5.4. Strategic Initiatives
- 9.5.6. Zoetis Services LLC
- 9.5.6.1. Participant's Overview
- 9.5.6.2. Financial Performance
- 9.5.6.3. Product Benchmarking
- 9.5.6.4. Strategic Initiatives
- 9.5.7. Orivet
- 9.5.7.1. Participant's Overview
- 9.5.7.2. Financial Performance
- 9.5.7.3. Product Benchmarking
- 9.5.7.4. Strategic Initiatives
- 9.5.8. Neogen Corporation
- 9.5.8.1. Participant's Overview
- 9.5.8.2. Financial Performance
- 9.5.8.3. Product Benchmarking
- 9.5.8.4. Strategic Initiatives
- 9.5.9. LIC
- 9.5.9.1. Participant's Overview
- 9.5.9.2. Financial Performance
- 9.5.9.3. Product Benchmarking
- 9.5.9.4. Strategic Initiatives
- 9.5.10. Animal Genetics, Inc.
- 9.5.10.1. Participant's Overview
- 9.5.10.2. Financial Performance
- 9.5.10.3. Product Benchmarking
- 9.5.10.4. Strategic Initiatives
- 9.5.11. VHLGenetics
- 9.5.11.1. Participant's Overview
- 9.5.11.2. Financial Performance
- 9.5.11.3. Product Benchmarking
- 9.5.11.4. Strategic Initiatives
- 9.5.12. AffinityDNA
- 9.5.12.1. Participant's Overview
- 9.5.12.2. Financial Performance
- 9.5.12.3. Product Benchmarking
- 9.5.12.4. Strategic Initiatives
Chapter 10. Key Takeaways